LifeScience Cell & Gene
IASO Bio Gains NMPA Approval for Multiple Myeloma Treatment IND
IASO Bio, a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody products, anno...
April 01, 2024 | News
EditCo Bio Launches with Acquisition of Synthego's Cell Engineering Divisions to Boost CRISPR Market Innovations
EditCo Bio, Inc. announced that it has launched its business with the acquisition of Synthego's engineered cell solutions and enhanced guide RNA business. ...
March 28, 2024 | News
Integrated DNA Technologies Launches Innovative Custom Vector Onboarding Tool to Streamline Gene Synthesis
Integrated DNA Technologies (IDT), a global leader in genomics solutions, announced the expansion of its gene synthesis services with the launch of a...
March 28, 2024 | News
Nanoscope Therapeutics Achieves Breakthrough in Retinitis Pigmentosa Treatment with MCO-010 Gene Therapy
Nanoscope Therapeutics, a pioneering biotechnology firm, unveiled groundbreaking results from the Phase 2b RESTORE trial of MCO-010...
March 27, 2024 | News
Andelyn Biosciences and Grace Science Partner on Gene Therapy for Rare Disease
Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has par...
March 26, 2024 | News
NeuExcell Therapeutics Launches Pioneering Gene Therapy Trial for Glioblastoma Patients
NeuExcell Therapeutics, a leading biotechnology company focused on in vivo neural regenerative therapies, announces the successful dosing of the ...
March 22, 2024 | News
European Commission Approves Bristol Myers Squibb’s Abecma as First Earlier-Line CAR T Therapy for Multiple Myeloma"
Bristol Myers Squibb announced a significant advancement in the treatment of multiple myeloma with the European Commission's approval of Abecma® (ideca...
March 21, 2024 | News
FDA Greenlights Lenmeldy, First Gene Therapy for Devastating Genetic Disorder Metachromatic Leukodystrophy
Metachromatic leukodystrophy is a debilitating, rare genetic disease affecting the brain and nervous system. It is caused by a deficiency of an enzyme call...
March 19, 2024 | News
Bristol Myers Squibb’s Breyanzi Approved as First CAR T Cell Therapy for CLL/SLL
Breyanzi offers a personalized treatment option delivered as a one-time infusion that provides deep and durable responses for patients wit...
March 15, 2024 | News
CAIR Launches Revolutionary CARES Copilot 1.0, Elevating AI in Healthcare
The Centre for Artificial Intelligence and Robotics (CAIR), under the Hong Kong Institute of Science & Innovation, Chinese Acad...
March 12, 2024 | News
ACROBiosystems Launches Initiative to Boost Ex Vivo Cell Manufacturing Support
ACROBiosystems, one of the leading providers of innovative tools and solutions used from discovery to the clinic, has announced a new corporate initiative ...
March 05, 2024 | News
CARsgen Therapeutics Receives NMPA Approval for Breakthrough Multiple Myeloma CAR T-Cell Therapy
CARsgen Therapeutics, a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that t...
March 04, 2024 | News
Andelyn Biosciences Selected for FNIH Gene Therapy Programs
Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has been sele...
February 29, 2024 | News
Immunofoco Achieves Historic Dual IND Approval for Groundbreaking EpCAM CAR-T Therapy
EpCAM, known for its presence in circulating tumor cells (CTCs) and high expression in primary and metastatic lesions of gastrointestinal tumors, r...
February 26, 2024 | News
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
- Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore
- Padraig McDonnell Takes Helm as Agilent Technologies' New CEO, Pledges to Elevate Scientific Impact
- Agilent Singapore and Malaysia Hosts CEO Transition Event: Celebrating Leadership and Welcoming New CEO
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
News
Editor Picks
